|
US20050085555A1
(en)
*
|
1997-08-21 |
2005-04-21 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
US20030013772A1
(en)
*
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
BR0010700A
(pt)
|
1999-04-30 |
2002-02-13 |
Slil Biomedical Corp |
Conjugados análogos de poliamina e conjugados de quinona como terapias para cânceres e doenças na próstata
|
|
HK1040993B
(en)
*
|
1999-04-30 |
2006-11-10 |
Cellgate, Inc. |
Polyamines and their use in therapy
|
|
AU2002235126A1
(en)
|
2000-11-08 |
2002-05-21 |
Slil Biomedical Corporation |
Novel polyamine analog-amino acid conjugates useful as anticancer agents
|
|
EP1436246A1
(en)
*
|
2001-10-16 |
2004-07-14 |
SLIL Biomedical Corporation |
Oligoamine compounds and derivatives thereof for cancer therapy
|
|
JP2004189714A
(ja)
*
|
2002-12-09 |
2004-07-08 |
Rasanen Tiina-Liisa |
すい臓炎の治療と予防ならびに肝臓再生機能の誘導のための薬剤
|
|
WO2007035703A1
(en)
|
2005-09-20 |
2007-03-29 |
Schering Corporation |
1- [ [1- [ (2-amin0-6-methyl-4-pyridinyl) methyl] -4-flu0r0-4-piperidinyl,] carbonyl] -4- [2- (2-pyridinyl) -3h-imidaz0 [4 , 5-b] pyridin-3-yl] piperidine useful as histamine h3 antagonist
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8153611B2
(en)
*
|
2007-06-28 |
2012-04-10 |
Basf Beauty Care Solutions France S.A.S. |
Use of sulfated oligosaccharides as slimming cosmetic ingredients
|
|
ES2700111T3
(es)
*
|
2007-06-28 |
2019-02-14 |
Basf Beauty Care Solutions France Sas |
Composición adelgazante
|
|
FR2917971B1
(fr)
|
2007-06-28 |
2009-10-23 |
Engelhard Lyon Soc Par Actions |
Composition amincissante
|
|
KR20100075643A
(ko)
|
2007-10-22 |
2010-07-02 |
쉐링 코포레이션 |
비사이클릭 헤테로사이클 유도체 및 ｇｐｒ119의 활성의 조절인자로서의 이의 용도
|
|
CA2724426A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
RU2392933C2
(ru)
*
|
2008-07-18 |
2010-06-27 |
Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) |
Средство, обладающее гиполипидемическими свойствами
|
|
EP2318388A2
(en)
|
2008-07-23 |
2011-05-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
|
WO2010039789A1
(en)
|
2008-10-03 |
2010-04-08 |
Schering Corporation |
Spiro-imidazolone derivatives as glucagon receptor antagonists
|
|
CA2739491A1
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
|
EP2379547A1
(en)
|
2008-12-16 |
2011-10-26 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
US20110245267A1
(en)
|
2008-12-19 |
2011-10-06 |
Schering Plough Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
|
EP2379564A1
(en)
|
2008-12-19 |
2011-10-26 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
|
US8722882B2
(en)
|
2008-12-23 |
2014-05-13 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
US8410122B2
(en)
|
2008-12-23 |
2013-04-02 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
EP2408744A1
(en)
|
2009-03-18 |
2012-01-25 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
|
US8580807B2
(en)
|
2009-04-03 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
US8470773B2
(en)
|
2009-06-12 |
2013-06-25 |
Merck Sharp & Dohme Corp. |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
|
WO2011031628A1
(en)
|
2009-09-14 |
2011-03-17 |
Schering Corporation |
Inhibitors of diacylglycerol acyltransferase
|
|
EP2485735B1
(en)
|
2009-10-08 |
2015-07-29 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (fabp)
|
|
US9409918B2
(en)
|
2009-10-29 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
|
US8912206B2
(en)
|
2009-11-23 |
2014-12-16 |
Merck Sharp & Dohme Corp. |
Pyrimidine ether derivatives and methods of use thereof
|
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
|
WO2011066137A1
(en)
|
2009-11-24 |
2011-06-03 |
Schering Corporation |
Substituted biaryl derivatives and methods of use thereof
|
|
US9173886B2
(en)
*
|
2010-03-12 |
2015-11-03 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
ITMI20130555A1
(it)
*
|
2013-04-09 |
2014-10-10 |
Giuliani Spa |
Composizione farmaceutica o cosmetica per contrastare l¿invecchiamento della pelle attraverso un¿azione antiinfiammatoria
|
|
CN105764916B
(zh)
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|